[1]
A. Imhof, D. J. Schaer, U. Schwarz, and U. Schanz, “Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring”, Swiss Med Wkly, vol. 136, no. 4546, pp. 739–742, Nov. 2006.